Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses

Published:2018-09 Issue: Volume:460 Page:51-62
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Shukla Girja S.,Sun Yu-Jing,Pero Stephanie C.,Sholler Giselle S.,Krag David N.

Funder

Cancer Research Foundation

Beat NB Foundation

University of Vermont

Department of Surgery

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference48 articles.

1. Signatures of mutational processes in human cancer;Alexandrov;Nature,2013

2. Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy;Angelova;Genome Biol.,2015

3. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer;Balachandran;Nature,2017

4. Amplification and purification of T4-like Escherichia coli phages for phage therapy: from laboratory to pilot scale;Bourdin;Appl. Environ. Microbiol.,2014

5. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy;Bruttin;Antimicrob. Agents Chemother.,2005

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review on Phage Therapy and Phage-Based Drug Development;Antibiotics;2024-09-11

2. Cancer therapy via neoepitope-specific monoclonal antibody cocktails;2024-08-06

3. Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapy;Drug Development Research;2024-08

4. An Engineered M13 Filamentous Nanoparticle as an Antigen Carrier for a Malignant Melanoma Immunotherapeutic Strategy;Viruses;2024-02-01

5. The Value of Microbes in Cancer Neoantigen Immunotherapy;Pharmaceutics;2023-08-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3